Physician profile
Bryan William Brooks
NPI 1184006348
$5,387.73
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.37 · 2020: $96.87 · 2021: $97.46 · 2022: $9.40 · 2023: $239 · 2024: $4,896.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Travel and Lodging: $337 · Food and Beverage: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Travel and Lodging | $336.57 |
| Food and Beverage | $299.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,016.16 | 2023-2024 | Da Vinci Surgical System |
| Abbvie INC. | $150.66 | 2019-2021 | |
| Hologic Sales and Service, LLC | $75.55 | 2023-2024 | Acessa Provu System, Third Wave, Thinprep 2000 Processor |
| Lupin INC. | $34.87 | 2019-2020 | |
| Astellas Pharma US INC | $21.69 | 2023 | Veozah |
| Roche Diagnostics Corporation | $19.50 | 2020 | |
| Harrow Eye, LLC | $16.95 | 2024 | Vevye |
| Organon LLC | $14.68 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.44 | 2021 | |
| Exeltis, USA INC. | $12.19 | 2021 | |
| Amag Pharmaceuticals, INC. | $12.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.